Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking

被引:1
|
作者
Wang, Yixuan [1 ]
Tao, Xiaoyu [1 ]
Gao, Yifei [1 ]
Jin, Zhengsen [1 ]
Guo, Siyu [1 ]
Li, Zhenjiang [2 ]
Wang, Mengmeng [3 ]
Zhao, Ruoqi [1 ]
Zhou, Wei [4 ]
Wu, Jiarui [1 ,5 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing, Peoples R China
[2] Shineway Pharmaceut Grp Ltd, Shijiazhuang, Peoples R China
[3] World Federat Chinese Med Soc, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Beijing, Peoples R China
[5] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing 102401, Peoples R China
基金
中国国家自然科学基金;
关键词
cervical spondylosis; mechanism of action; network pharmacology; Shujin Tongluo granules; PREDICTION;
D O I
10.1097/MD.0000000000034030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:To investigate the potential active ingredients and possible mechanisms of Shujin Tongluo granules (SJTLG) in the treatment of cervical spondylosis (CS) by network pharmacology and molecular docking. Methods:The active ingredients and potential targets of SJTLG were obtained through databases such as traditional Chinese medicine system (TCMSP) and BATMAN-traditional Chinese medicine (TCM), and the relevant human targets of CS were identified through databases such as OMIM, GeneCards, and DisGeNET. The intersection targets were imported into STRING for protein-protein interaction (PPI) analysis. The obtained data were imported into Cytoscape 3.9.0 software for visualization, and module analysis was performed using the MCODE plug-in. The representative targets were screened through the Metascape website for pathway enrichment analysis in Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Cytoscape software was used to build networks such as "drug-compound-target" and "drug-compound-target-pathway." Finally, the key targets were selected for molecular docking with the corresponding compounds by Autodock Tools 1.5.7 and visualized by PyMol. Results:A total of 132 active compounds and 996 targets from SJTLG and 678 targets from CS were screened with 116 intersection targets. The key targets were AKT1, GAPDH, ALB, IL-6, TP53, TNF, VEGFA, IL-1 & beta;, EGFR, HSP90AA1, ESR1, and JUN. The results of GO and KEGG enrichment analysis showed that the treatment of CS was mainly related to biological processes such as cellular response to nitrogen compound, cellular response to organonitrogen compound, and positive regulation of locomotion, and the targets were mainly focused on pathways in cancer, Kaposi sarcoma-associated herpesvirus infection, PI3K-Akt signaling pathway, lipid, and atherosclerosis. Molecular docking results showed that the minimum binding energy between the core targets and the corresponding compound was Conclusion:This study preliminarily elucidates the potential active ingredients and mechanism of anti-inflammatory, analgesic, microcirculation improvement, vasodilation, osteoporosis inhibition and nerve nutrition effects of SJTLG in the treatment of CS and provides a reference for its clinical application.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Mechanism of ShuiJingDan in Treating Acute Gouty Arthritis Flares Based on Network Pharmacology and Molecular Docking
    Liu, Qingsong
    Li, Lunyu
    Zheng, Dan
    Jin, Songlin
    Guan, Xiaotian
    Fu, Zeting
    Xiong, Zhigang
    Ding, Haili
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 3493 - 3505
  • [22] An investigation of the mechanism of ZiyinDianji decoction in treating follicular dysplasia based on network pharmacology and molecular docking
    Feng, Xue
    Zhou, Huifang
    Lu, Wentian
    Liu, Xinyuan
    Wu, Yue
    Dai, Yaxin
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (13) : 120 - 127
  • [23] Evaluation of the Mechanism of Sinomenii Caulis in Treating Ulcerative Colitis based on Network Pharmacology and Molecular Docking
    Tian, Juan
    Yang, Changgeng
    Wang, Yun
    Zhou, Canlin
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2024, 20 (03) : 195 - 207
  • [24] Decoding the Mechanism of Huanglian Jiedu Decoction in Treating Pneumonia Based on Network Pharmacology and Molecular Docking
    Li, Xianhai
    Tang, Hua
    Tang, Qiang
    Chen, Wei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [25] Study on the mechanism of Wumei San in treating piglet diarrhea using network pharmacology and molecular docking
    Yin, Huihui
    Liu, Wei
    Ji, Xiaoyu
    Yan, Guoqing
    Zeng, Xueyan
    Zhao, Wu
    Wang, Yanhua
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [26] Research on the Mechanism of Kaempferol for Treating Senile Osteoporosis by Network Pharmacology and Molecular Docking
    Tang, Fuyu
    Zhang, Peng
    Zhao, Wenhua
    Zhu, Guangye
    Shen, Gengyang
    Chen, Honglin
    Yu, Xiang
    Zhang, Zhida
    Shang, Qi
    Liang, De
    Jiang, Xiaobing
    Ren, Hui
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [27] Mechanism of β-sitosterol in treating keloids: Network pharmacology, molecular docking and experimental verification
    Huo, Pingping
    Li, Zhouna
    Jin, Shan
    Wang, Sujie
    Luo, Yinli
    Zhu, Lianhua
    Jin, Zhehu
    MOLECULAR MEDICINE REPORTS, 2025, 31 (04)
  • [28] The mechanism of quercetin in treating intracerebral hemorrhage was investigated by network pharmacology and molecular docking
    Zhang, Zi-You
    Lv, Xiao-Yu
    Zhou, Xin-Pei
    Xiang, Hai-Tao
    He, Yu-Song
    Li, Xu-Yang
    Yan, Ting-Ting
    Zhong, Yang-Yang
    Li, Zhuang
    Zhang, Ben-Si
    MEDICINE, 2024, 103 (40)
  • [29] Molecular mechanism of quercetin in treating RA-ILD based on network pharmacology, molecular docking, and experimental validation
    Jing Wang
    Zhichao Wang
    Yang Zhao
    Le Bai
    Yun Wei
    Tongxing Huang
    Yong Xu
    Xianmei Zhou
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 3077 - 3092
  • [30] Molecular mechanism of quercetin in treating RA-ILD based on network pharmacology, molecular docking, and experimental validation
    Wang, Jing
    Wang, Zhichao
    Zhao, Yang
    Bai, Le
    Wei, Yun
    Huang, Tongxing
    Xu, Yong
    Zhou, Xianmei
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (05) : 3077 - 3092